Leadership
Dedicated to upholding the mission of Winship Cancer Institute, the leadership team oversees the ground breaking research and the world renowned patient care at Winship.
Suresh S. Ramalingam, MD, FACP, FASCO
- Executive Director
- Winship Cancer Institute of Emory University
As Executive Director, Dr. Ramalingam leads the growth and development of cancer research, clinical care, and education at Winship Cancer Institute of Emory University.
Adam Marcus, PhD
- Deputy Director
- Winship Cancer Institute of Emory University
- Scientific Director, Integrated Cellular Imaging Core
- Winship Cancer Institute of Emory University
As Deputy Director, Dr. Marcus leads the integration of the research, clinical, and educational components within Winship Cancer Institute of Emory University.
Lawrence Boise, PhD
- Associate Director for Education and Training
- Winship Cancer Institute of Emory University
Dr. Boise leads and coordinates research education, training, and mentorship activities at the cancer center as well as cultivates additional cancer-specific educational opportunities across the spectrum of learners.
Theresa W. Gillespie, PhD, MA, BSN, FAAN
- Associate Director for Community Outreach and Engagement
- Winship Cancer Institute of Emory University
Dr. Gillespie provides vision and oversight for Winship’s community-facing activities through its Community Outreach and Engagement program.
Charise Gleason, MSN, NP-BC, AOCNP
- Advance Practice Provider Chief
- Winship Cancer Institute of Emory University
Ms. Gleason leads the Physician Assistants and Nurse Practitioners for Winship across Emory Healthcare overseeing clinical practice, quality, safety, education, and the APP fellowship.
Ildemaro J. González, MBA
- Chief Diversity Officer
- Winship Cancer Institute of Emory University
Mr. Gonzalez oversees diversity, equity, and inclusion strategies at Winship to impact the Institute's research, clinical care, people, and community priorities while ensuring coordination and alignment with Emory Healthcare and Emory University.
Douglas K. Graham, MD, PhD
- Chief and William G. Woods, M.D. Chair
- Aflac Cancer and Blood Disorders Center
Dr. Graham leads the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta.
Kimberly F. Kerstann, PhD
- Chief Administrative Officer
- Winship Cancer Institute of Emory University
As a member of the Winship senior leadership team, Dr. Kerstann oversees Winship's administrative, business, and clinical research operations.
Gregory B. Lesinski, PhD, MPH
- Associate Director for Basic Research and Shared Resources
- Winship Cancer Institute of Emory University
Dr. Lesinski provides oversight and direction for the development and growth of Winship's basic scientific activities across the cancer center’s four research programs.
Sagar Lonial, MD, FACP
- Chief Medical Officer
- Winship Cancer Institute of Emory University
Internationally recognized as a leading authority in multiple myeloma treatment and research, Dr. Lonial collaborates with leadership as Chief Medical Officer to coordinate and enhance clinical services and patient care throughout Winship.
Stacy L. Palmer, MBA
- Vice President of Cancer Clinical Administration and Strategy
- Winship Cancer Institute of Emory University
Ms. Palmer is responsible for coordinating Winship's clinical strategy and supporting standardization of cancer care across Emory Healthcare's clinical sites and partners.
Maria C. Russell, MD
- Interim Chief Quality Officer
- Winship Cancer Institute of Emory University
A surgical expert in the care of complex gastrointestinal and hepatobiliary malignancies, Dr. Russell as Chief Quality Officer collaborates with Winship leadership on tracking and improving patient services and satisfaction as well as focusing on cancer outcomes.
Edmund K. Waller, MD, PhD, FACP
- Interim Associate Director of Clinical Research
- Winship Cancer Institute of Emory University
Dr. Waller specializes in bone marrow transplants for acute leukemia, myelodysplastic syndrome, myeloproliferative neoplasms, lymphoma, aplastic anemia, sickle cell disease and in the management of graft-versus-host disease.